Spyre Therapeutics, Inc. SYRE Operating margin

Operating margin at other companies

Johnson & JohnsonJNJ

26.5%+2.8pp

AbbVieABBV

26.2%—

Absci CorporationABSI

-6,723%-14,525pp

Relay Therapeutics, Inc.RLAY

-2,999.4%-637pp

Shattuck Labs, Inc.STTK

-5,266.4%-9,520pp

CytomX TherapeuticsCTMX

-476.2%-507pp

FAQ

What is Spyre Therapeutics, Inc.'s operating margin?

Spyre Therapeutics, Inc. (SYRE) reported operating margin of -39,428.9% in Q1 2024.

How has Spyre Therapeutics, Inc.'s operating margin changed year-over-year?

Spyre Therapeutics, Inc.'s operating margin decreased by 480.4% year-over-year, from -6,793.6% to -39,428.9%.

What is the long-term trend for Spyre Therapeutics, Inc.'s operating margin?

Over 2 years (2021 to 2023), Spyre Therapeutics, Inc.'s operating margin has grown at a 783.5% compound annual growth rate (CAGR), from -350.3% to -27,348%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.